EULAR REPORT

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

M Dougados¹, N Betteridge², G R Burmester³, L Euller-Ziegler⁴, F Guillemin⁵, J Hirvonen⁶, J Lloyd⁷, S Ozen⁸, J A P Da Silva⁹, P Emery¹⁰, J R Kalden¹¹, T Kvien¹², M Matucci-Cerinic¹³, J Smolen¹⁴

¹ Clinique de Rhumatologie B Groupe, Hospitalier Cochin, Paris 75014, France
² Arthritis Care, 18 Stephenson Way, London NW1 2HD, UK
³ Department of Rheumatology and Clinical Immunology, Charite Humboldt University, Schumanstrasse 20–21, D 10117 Berlin, Germany
⁴ Service de Rheumatologie, Archet Hospital, route de Saint-Antoine Ginestiere, 06202 Nice, Cedex 3, France
⁵ Ecole de Santé Publique, Faculté de Médecine, BP 184, 54505 Vandoeuvre les Nancy, France
⁶ Suomen Reumalittory, Iso Roobertinkatu 20–22A, Helsinki FIN-01200, Finland
⁷ Brunel University, Department of Health Studies, Borough Rd, Isleworth TW7 5DU, UK
⁸ Hacettepe University, Department of Paediatrics, 06100 Ankara, Turkey
⁹ Nucleo de Reumatologia, Hospitalais de Universidade de Coimbra, Servicio de Medicina III et Reumatologia, 3000-075 Coimbra, Portugal
¹⁰ Academic Unit of Musculoskeletal Diseases, Department of Rheumatology, 1st Floor, Leeds LS1 3EX, UK
¹¹ Institut for Clinical Immun & Rheumatism, University Erlangen-Nurenberg, Krakenhaustrasse 2, Erlangen 91054, Germany
¹² Oslo City Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23 Vinderen, Oslo N 0319, Norway
¹³ Department Medicine/Division of Rheumatology, University of Florence, Villa Monna Tessa, Viale Pleraccini 18, Florence 50139, Italy
¹⁴ Aligemeines Krankenhaus, Klinik für Innere Medizin II, Klinische Abteilung für Rheumatologie, Wahringe Gürtel 18–20, Vienna 1090, Austria

Correspondence to:
Correspondence to:
Professor M Dougados
maxime.dougados@cch.ap-hop-paris.fr

Accepted 20 June 2004

Keywords: EULAR; guidelines; procedures; recommendations

The first 150 words of the full text of this article appear below.

It is the objective of the EULAR executive committee to promote actions and/or projects aimed at improving the knowledge and/or the recognition of musculoskeletal disorders.

The chief aim is to contribute to the improvement of outcome of patients with rheumatic disorders. Apart from the projects devoted to education and research, projects aimed at facilitating the conduct of clinical studies or at improving the management of musculoskeletal disorders are welcome. Such studies can be categorised in four sections:

• Studies dedicated to a proposal for classification and/or diagnostic criteria
  
• Recommendations for designing and/or conducting clinical trials in specific musculoskeletal disorders
  
• Recommendations for monitoring and/or management and/or treatment of specific musculoskeletal disorders
  
• Standardisation of (laboratory and other) procedures.
  

It is the objective of the EULAR executive committee to maintain and to homogenise a high level of intrinsic quality and comparability of such studies.

To achieve such an objective it appeared that the definition and . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kiltz, U, van der Heijde, D, Mielants, H, Feldtkeller, E, Braun, J, on behalf of the PARE/EULAR patient initiative gro, (2009). ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis 68: 1381-1386 [Abstract] [Full Text]  
• Avouac, J, Kowal-Bielecka, O, Landewe, R, Chwiesko, S, Miniati, I, Czirjak, L, Clements, P, Denton, C, Farge, D, Fligelstone, K, Foldvari, I, Furst, D E, Muller-Ladner, U, Seibold, J, Silver, R M, Takehara, K, Toth, B G., Tyndall, A, Valentini, G, van den Hoogen, F, Wigley, F, Zulian, F, Matucci-Cerinic, M, and EUSTAR coauthors, (2009). European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis 68: 629-634 [Abstract] [Full Text]  
• Kowal-Bielecka, O, Landewe, R, Avouac, J, Chwiesko, S, Miniati, I, Czirjak, L, Clements, P, Denton, C, Farge, D, Fligelstone, K, Foldvari, I, Furst, D E, Muller-Ladner, U, Seibold, J, Silver, R M, Takehara, K, Toth, B G., Tyndall, A, Valentini, G, van den Hoogen, F, Wigley, F, Zulian, F, Matucci-Cerinic, M., and the EUSTAR co-authors, (2009). EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68: 620-628 [Abstract] [Full Text]  
• Gordon, C, Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I-M, Houssiau, F, Huizinga, T W J, Isenberg, D, Kallenberg, C G M, Khamashta, M A, Piette, J-C, Schneider, M, Smolen, J S, Sturfelt, G, Tincani, A, Van Vollenhoven, R, Boumpas, D T (2009). EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Ann Rheum Dis 68: 470-476 [Abstract] [Full Text]  
• Bertsias, G K, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Boumpas, D T, Gordon, C (2009). EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. Ann Rheum Dis 68: 477-483 [Abstract] [Full Text]  
• Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R, for the European Vasculitis Study Group, (2009). EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317 [Abstract] [Full Text]  
• Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R, for the European Vasculitis Study Group, (2009). EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68: 318-323 [Abstract] [Full Text]  
• Zhang, W, Doherty, M, Leeb, B F, Alekseeva, L, Arden, N K, Bijlsma, J W, Dincer, F, Dziedzic, K, Hauselmann, H J, Kaklamanis, P, Kloppenburg, M, Lohmander, L S, Maheu, E, Martin-Mola, E, Pavelka, K, Punzi, L, Reiter, S, Smolen, J, Verbruggen, G, Watt, I, Zimmermann-Gorska, I (2009). EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 68: 8-17 [Abstract] [Full Text]  
• Hatemi, G, Silman, A, Bang, D, Bodaghi, B, Chamberlain, A M, Gul, A, Houman, M H, Kotter, I, Olivieri, I, Salvarani, C, Sfikakis, P P, Siva, A, Stanford, M R, Stubiger, N, Yurdakul, S, Yazici, H (2008). EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 67: 1656-1662 [Abstract] [Full Text]  
• Aletaha, D, Landewe, R, Karonitsch, T, Bathon, J, Boers, M, Bombardier, C, Bombardieri, S, Choi, H, Combe, B, Dougados, M, Emery, P, Gomez-Reino, J, Keystone, E, Koch, G, Kvien, T K, Martin-Mola, E, Matucci-Cerinic, M, Michaud, K, O'Dell, J, Paulus, H, Pincus, T, Richards, P, Simon, L, Siegel, J, Smolen, J S, Sokka, T, Strand, V, Tugwell, P, van der Heijde, D, van Riel, P, Vlad, S, van Vollenhoven, R, Ward, M, Weinblatt, M, Wells, G, White, B, Wolfe, F, Zhang, B, Zink, A, Felson, D (2008). Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 67: 1360-1364 [Abstract] [Full Text]  
• Mukhtyar, C, Flossmann, O, Hellmich, B, Bacon, P, Cid, M, Cohen-Tervaert, J W, Gross, W L, Guillevin, L, Jayne, D, Mahr, A, Merkel, P A, Raspe, H, Scott, D, Witter, J, Yazici, H, Luqmani, R A, on behalf of the European Vasculitis Study Group (, (2008). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67: 1004-1010 [Abstract] [Full Text]  
• Gossec, L, Dougados, M, Phillips, C, Hammoudeh, M, de Vlam, K, Pavelka, K, Pham, T, Braun, J, Sieper, J, Olivieri, I, van der Heijde, D, Collantes, E, Stone, M, Kvien, T K, on behalf of ASAS (ASsessment in AS international, (2008). Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Ann Rheum Dis 67: 782-788 [Abstract] [Full Text]  
• Carville, S F, Arendt-Nielsen, S, Bliddal, H, Blotman, F, Branco, J C, Buskila, D, Da Silva, J A P, Danneskiold-Samsoe, B, Dincer, F, Henriksson, C, Henriksson, K G, Kosek, E, Longley, K, McCarthy, G M, Perrot, S, Puszczewicz, M, Sarzi-Puttini, P, Silman, A, Spath, M, Choy, E H (2008). EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67: 536-541 [Abstract] [Full Text]  
• Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T (2008). EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67: 195-205 [Abstract] [Full Text]  
• Mouthon, L, Rannou, F, Berezne, A, Pagnoux, C, Arene, J-P, Fois, E, Cabane, J, Guillevin, L, Revel, M, Fermanian, J, Poiraudeau, S (2007). Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis 66: 1651-1655 [Abstract] [Full Text]  
• Hoes, J N, Jacobs, J W G, Boers, M, Boumpas, D, Buttgereit, F, Caeyers, N, Choy, E H, Cutolo, M, Da Silva, J A P, Esselens, G, Guillevin, L, Hafstrom, I, Kirwan, J R, Rovensky, J, Russell, A, Saag, K G, Svensson, B, Westhovens, R, Zeidler, H, Bijlsma, J W J (2007). EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66: 1560-1567 [Abstract] [Full Text]  
• Hellmich, B., Flossmann, O., Gross, W. L, Bacon, P., Willem Cohen-Tervaert, J., Guillevin, L., Jayne, D., Mahr, A., Merkel, P. A, Raspe, H., Scott, D. G I, Witter, J., Yazici, H., Luqmani, R. A, on behalf of the European Vasculitis Study Group, (2007). EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66: 605-617 [Abstract] [Full Text]  
• Combe, B, Landewe, R, Lukas, C, Bolosiu, H D, Breedveld, F, Dougados, M, Emery, P, Ferraccioli, G, Hazes, J M W, Klareskog, L, Machold, K, Martin-Mola, E, Nielsen, H, Silman, A, Smolen, J, Yazici, H (2007). EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66: 34-45 [Abstract] [Full Text]  
• Zochling, J, van der Heijde, D, Dougados, M, Braun, J (2006). The process of producing recommendations for rheumatic diseases: what is evidence?. Ann Rheum Dis 65: 979-979 [Full Text]  
• Zochling, J, van der Heijde, D, Burgos-Vargas, R, Collantes, E, Davis, J C Jr, Dijkmans, B, Dougados, M, Geher, P, Inman, R D, Khan, M A, Kvien, T K, Leirisalo-Repo, M, Olivieri, I, Pavelka, K, Sieper, J, Stucki, G, Sturrock, R D, van der Linden, S, Wendling, D, Bohm, H, van Royen, B J, Braun, J (2006). ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442-452 [Abstract] [Full Text]